Shaolin Capital Management LLC acquired a new position in shares of Adagio Medical Holdings, Inc. (NASDAQ:ADGM – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 140,000 shares of the company’s stock, valued at approximately $361,000. Shaolin Capital Management LLC owned about 1.05% of Adagio Medical as of its most recent SEC filing.
Separately, RTW Investments LP acquired a new stake in shares of Adagio Medical in the third quarter valued at approximately $540,000. 48.08% of the stock is currently owned by institutional investors.
Adagio Medical Stock Performance
ADGM stock opened at $2.41 on Wednesday. The company has a debt-to-equity ratio of 0.18, a current ratio of 4.42 and a quick ratio of 3.90. The stock has a 50 day moving average of $2.66. Adagio Medical Holdings, Inc. has a fifty-two week low of $1.69 and a fifty-two week high of $9.34.
Adagio Medical Profile
Adagio Medical Holdings, Inc, a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.
Read More
- Five stocks we like better than Adagio Medical
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Time to Take Bitcoin Profits as $100K Milestone Nears?
- Buy P&G Now, Before It Sets A New All-Time High
- 4 Stocks That Crushed Analyst Estimates by More Than Double
- How to Invest in Small Cap Stocks
- Neos S&P 500(R) High Income ETF Harnesses the Power of Options
Receive News & Ratings for Adagio Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adagio Medical and related companies with MarketBeat.com's FREE daily email newsletter.
